Recent News

By Region: Europe

Illnesses Prompt Fears of Anthrax Strike at British Army Facility

(Global Security Newswire) Several personnel at the British army’s primary intelligence site showed significant symptoms of illness on March 30, raising later-disproven suspicions that an anthrax attack had occurred and bringing attention to the site’s vulnerability to a biological or chemical strike, the London Daily Star reported on Sunday. The incident forced workers to vacate  Read More »

H5N1 Answers Wanted

(The Biological SCENE) Last week saw more questions and, maybe, a few answers about the drawn-out controversy over recent H5N1 avian flu research. After exchanges of letters and a congressional hearing, cooler heads seemed to prevail with signs of a consensus among stakeholders. The week began with an April 23 letter from Rep. F. James  Read More »

Cowpox infection in US lab worker called a first

(CIDRAP News) A US laboratory worker contracted a painful, slow-healing cowpox virus infection on the job in 2010, marking the first such case reported in the United States, though the virus, a relative of smallpox, is known in Europe and Russia, according to a study published yesterday. The infected researcher had not worked with cowpox  Read More »

Dutch officials approve publication of Fouchier’s H5N1 study

(CIDRAP News) The Dutch government has granted virologist Ron Fouchier, PhD, an export license that allows him to submit his much-debated H5N1 transmissibility paper to Science, according to a ScienceInsider report published today. “Now we can move on,” Fouchier told ScienceInsider. His report details how he and his colleagues developed an H5N1 virus capable of  Read More »

Secret Briefing Helped Sway H5N1 Flu Papers Decision

(Science AAAS) A classified briefing from U.S. intelligence officials helped persuade a majority of members of a government advisory board that the benefits of publishing two controversial H5N1 avian influenza studies outweighed the risks, according to testimony presented yesterday at a U.S. Senate hearing. The late March briefing to the National Science Advisory Board for  Read More »